<h4>Introduction</h4>Previous studies have demonstrated that programmed cell death-ligand 1 (PD-L1) serves as biomarker for poor prognosis and survival in advanced-stage non-small cell lung cancer (NSCLC) patients. Here, CD274 is linked to non-small cell lung carcinoma.